Furthermore, the administration of interleukin-1β (IL-1β), interleukin-2 (IL-2), and interleukin-6 (IL-6) increased norepinephrine (NE) and reduced dopamine (DA) levels, which was similar to those seen in ADHD (7). This evidence concerns the gene IL6 and attention deficit-hyperactivity disorder.